{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:43:22Z","timestamp":1786236202113,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2025-I2M-TS-05"],"award-info":[{"award-number":["2025-I2M-TS-05"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179141","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:18:40Z","timestamp":1784009920000},"page":"179141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mitochondrial complex I inhibition remodels the PDAC fibrotic microenvironment via LOXL2 suppression to potentiate chemo-immunotherapy"],"prefix":"10.1016","volume":"1030","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2611-2274","authenticated-orcid":false,"given":"Ziyi","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1583-0678","authenticated-orcid":false,"given":"Jinyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4875-0314","authenticated-orcid":false,"given":"Kaihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4192-0529","authenticated-orcid":false,"given":"Jiaxing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9060-3988","authenticated-orcid":false,"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179141_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/gutjnl-2021-325564","article-title":"Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma","volume":"72","author":"Alonso-Nocelo","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2026.179141_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2026.179141_bib3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ccell.2022.06.011","article-title":"Oncogenic collagen I homotrimers from cancer cells bind to \u03b13\u03b21 integrin and impact tumor microbiome and immunity to promote pancreatic cancer","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2026.179141_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12951-023-01942-y","article-title":"Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP\/LOXL2 pathway","volume":"21","author":"Cheng","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejphar.2026.179141_bib5","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s43018-023-00614-y","article-title":"A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer","volume":"4","author":"Chitty","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejphar.2026.179141_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1158\/0008-5472.CAN-18-1334","article-title":"Antifibrotic therapy disrupts stromal barriers and modulates the immune landscape in pancreatic ductal adenocarcinoma","volume":"79","author":"Elahi-Gedwillo","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179141_bib7","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2011.06.047","article-title":"Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-\u03b2-catenin signaling to slow tumor progression","volume":"141","author":"Froeling","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2026.179141_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jcmgh.2020.05.004","article-title":"Differential contribution of pancreatic fibroblast subsets to the pancreatic cancer stroma","volume":"10","author":"Garcia","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179141_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.canlet.2015.10.025","article-title":"Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition","volume":"370","author":"Ju","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2026.179141_bib10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00109-023-02369-6","article-title":"The role of LOXL2 induced by glucose metabolism-activated NF-\u03baB in maintaining drug resistance through EMT and cancer stemness in gemcitabine-resistant PDAC","volume":"101","author":"Lee","year":"2023","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejphar.2026.179141_bib11","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.7150\/thno.62378","article-title":"Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2026.179141_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002068","article-title":"Safety and activity of the TGF\u03b2 receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer","volume":"9","author":"Melisi","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejphar.2026.179141_bib13","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.csbj.2023.04.003","article-title":"Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT","volume":"21","author":"Meng","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejphar.2026.179141_bib14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.15252\/emmm.201404827","article-title":"Targeting the LOX\/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy","volume":"7","author":"Miller","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179141_bib15","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","article-title":"Stromal biology and therapy in pancreatic cancer: a changing paradigm","volume":"64","author":"Neesse","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2026.179141_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201900631","article-title":"Sequential targeting TGF-\u03b2 signaling and KRAS mutation increases therapeutic efficacy in pancreatic cancer","volume":"15","author":"Pei","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.ejphar.2026.179141_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cell.2014.08.007","article-title":"Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy","volume":"159","author":"Sherman","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179141_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s40425-019-0725-7","article-title":"Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy","volume":"7","author":"Shi","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ejphar.2026.179141_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41419-025-07751-5","article-title":"MMA-induced LOXL2+ PSCs promote linear ECM alignment in the aging pancreas leading to pancreatic cancer progression","volume":"16","author":"Shi","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.179141_bib20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejphar.2026.179141_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413408","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma: an update on heterogeneity and therapeutic targeting","volume":"22","author":"Vaish","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179141_bib22","series-title":"Phase I Study of Defactinib Combined with Pembrolizumab and Gemcitabine in Patients with Advanced Cancer. Clinicaltrials.Gov","year":"2021"},{"key":"10.1016\/j.ejphar.2026.179141_bib23","article-title":"LOXL2 in cancer: regulation, downstream effectors and novel roles","volume":"1874","author":"Wen","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejphar.2026.179141_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/biom9100620","article-title":"YAP inhibition by nuciferine via AMPK-mediated downregulation of HMGCR sensitizes pancreatic cancer cells to gemcitabine","volume":"9","author":"Zhou","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.179141_bib25","article-title":"Mitochondria energy metabolism depression as novel adjuvant to sensitize radiotherapy and inhibit radiation induced-pulmonary fibrosis","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci. (Weinh.)"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:32:45Z","timestamp":1786235565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"alternative-id":["S0014299926006230"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179141","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial complex I inhibition remodels the PDAC fibrotic microenvironment via LOXL2 suppression to potentiate chemo-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179141"}}